ebay 易趣 达美航空 端来亚 = 爱立信 Delta 296.99亿市值 315.15亿市值 299.07亿市值 5.33 8.85 48.27 -1.72(-3.43%) +0.08(+0.91%) +0.03(+0.47%) 沃达丰(US) 纽柯钢铁 (p) 照普 269.80亿市值 257.74亿市值 258.31亿市值 111.69 28.62 10.42 -3.31(-2.87%) -0.36(-1.24%) +0.03(+0.29%) Pinterest Inc-A FOX 福克斯-A FOX 福克斯-B 247.83亿市值 218.08亿市值 228.54亿市值 55.12 32.23 50.83 -1.38(-2.44%) -1.33(-2.55%) -0.03(-0.09%) 哈里伯顿 陶氏 西部数据 203.15亿市值 171.08亿市值 172.66亿市值 28.74 49.49 19.90 -1.05(-3.52%) -1.14(-2.25%) -0.58(-2.83%) 华纳音乐 Dropbox Inc-A Lyft Inc-A lyft 80.46亿市值 138.50亿市值 6 ...

福克斯-A 沃达丰(US) ox 福克斯-B 249.63亿市值 258.68亿市值 230.38亿市值 51.24 10.44 55.52 +0.04(+0.43%) -0.98(-1.73%) -0.92(-1.76%) Pinterest Inc-A 陶氏 西部数据 217.30亿市值 208.03亿市值 177.32亿市值 32.12 29.43 50.83 -0.36(-1.21%) +0.20(+0.39%) -0.14(-0.45%) 哈里伯顿 华纳音乐 Dropbox Inc-A 140.51亿市值 80.23亿市值 174.52亿市值 20.30 26.95 28.50 -0.18(-0.88%) -0.23(-0.86%) -0.17(-0.59%) Lyft Inc-A IMAX Corp 68.54亿市值 14.56亿市值 16.30 27.09 -0.23(-1.42%) -0.02(-0.07%) @ JIN10.COM 金十数据 | 一个交易工具 27.60 89.97 605.48 -1.90(-2.06%) -1.04(-0.17%) -0.18(-0.65%) 加拿大皇家银 ...

金十图示：2025年05月20日（周二）美股热门股票行情一览（美股收盘） VISA HEF 7077.97亿市值 6768.97亿市值 5276.03亿市值 746.83 366.85 581.03 -5.38(-0.92%) -8.28(-1.10%) -1.05(-0.29%) 埃克森美孚 甲骨文 祭飞 5073.79亿市值 4523.40亿市值 4496.17亿市值 1192.23 104.96 160.34 +0.59(+0.05%) -1.51(-1.42%) +0.69(+0.44%) 强生 P&G | 宝浩 ss) 家得宝 3884.44亿市值 3748.80亿市值 3696.69亿市值 165.68 153.64 377.17 +0.91(+0.55%) -2.21(-0.58%) +1.15(+0.75%) 美国银行 可口可乐 阿斯麦 (acobela ASML 3366.00亿市值 2944.99亿市值 3086.16亿市值 748.82 71.70 44.69 -0.08(-0.18%) -0.23(-0.32%) -0.31(-0.04%) 联合健康 赛富时 T-Mobile US I ...

金十图示：2025年05月20日（周二）美股热门股票行情一览（美股盘初） +0.23(+0.20%) -0.32(-1.07%) -0.38(-0.53%) 纽约梅隆银行 巴克莱 * 纽蒙特 570.24亿市值 644.53亿市值 634.53亿市值 17.77 51.23 90.09 -0.24(-0.27%) +0.04(+0.23%) +0.30(+0.60%) ND 恩智浦半导体 四 德意志银行 CS Phillips 66 498.54亿市值 553.31亿市值 527.29亿市值 122.32 28.51 208.72 -0.05(-0.18%) -1.64(-0.78%) +0.14(+0.11%) 美国国际集团 斯伦贝谢 GM 通用汽车 AIG 484.69亿市值 480.33亿市值 471.50亿市值 49.96 84.10 34.66 -0.24(-0.29%) -0.07(-0.14%) -0.45(-1.27%) 福特汽车 淡水河谷 02) 本田汽车 427.26亿市值 418.55亿市值 428.26亿市值 10.77 29.49 9.80 +0.02(+0.18%) +0.22(+ ...

Market Capitalization Summary - Visa has a market capitalization of 678.98 billion, while Oracle stands at 507.00 billion [2] - Netflix's market cap is 458.85 billion, and ExxonMobil is at 447.70 billion [2] - Johnson & Johnson has a market cap of 386.33 billion, and Home Depot is at 376.88 billion [2] - Procter & Gamble's market cap is 366.93 billion, and Bank of America is at 337.13 billion [2] Stock Performance - Visa's stock decreased by 0.27% (-2.06) [2] - Oracle's stock increased by 0.52% (+3.05) [2] - Netflix's stock decreased by 0.02% (-0.18) [2] - ExxonMobil's stock decreased by 1.59% (-1.72) [2] Notable Increases - T-Mobile US Inc saw a significant increase of 8.21% (+23.98) [2] - Cisco's stock increased by 0.62% (+1.65) [2] - Pfizer's stock increased by 0.81% (+0.18) [4] Notable Decreases - AMD's stock decreased by 2.07% (-2.42) [3] - Ford's stock decreased by 0.57% (-0.06) [4] - General Motors' stock decreased by 0.69% (-0.35) [4] Additional Market Insights - The market capitalization of major companies like Coca-Cola and ASML is 294.71 billion and 309.65 billion respectively [2] - Companies like Starbucks and Intel have market caps of 96.15 billion and 93.32 billion respectively [5] - The overall market performance reflects a mix of gains and losses across various sectors, indicating volatility [3][4]

+2.63(+1.38%) +3.42(+0.70%) -0.39(-0.62%) 778.71亿市值 戴尔科技 高露洁 Coloate 779.92亿市值 739.99亿市值 91.31 114.11 29.30 -0.08(-0.07%) +0.08(+0.09%) -0.46(-1.53%) 巴克莱 PayPal Holdings = 纽约梅隆银行 PayPal InC 646.97亿市值 629.85亿市值 704.21亿市值 72.41 90.43 17.64 +0.23(+0.32%) +0.36(+0.40%) +0.22(+1.26%) 纽蒙特 德意志银行 慰智浦半导体 0 NP 530.77亿市值 563.51亿市值 552.44亿市值 210.10 50.63 28.46 +0.53(+1.06%) -2.46(-1.16%) +0.59(+2.13%) Phillips 66 AIG 美国国际集团 GM 通用汽车 lees 500.96亿市值 482.02亿市值 486.65亿市值 122.91 50.13 84.44 -1.62(-1.30%) -0.23(-0.47%) +0.11( ...

金十图示：2025年05月19日（周一）美股热门股票行情一览（美股盘初） PayPal Holdings 巴克莱 n 纽约梅隆银行 Inc 640.46亿市值 624.54亿市值 698.28亿市值 17.49 71.80 89.52 +0.07(+0.40%) -0.38(-0.53%) -0.55(-0.61%) 纽蒙特 德意志银行 恩智浦半导体 0 9 559.78亿市值 550.60亿市值 528.75亿市值 28.37 50.30 209.30 -3.26(-1.53%) +0.20(+0.39%) +0.50(+1.79%) Phillips 66 美国国际集团 斯伦贝谢 AIG 499.41亿市值 484.12亿市值 476.33亿市值 122.53 84.00 35.02 -0.75(-2.10%) -2.00(-1.61%) -0.33(-0.39%) * 瓦莱罗能源 淡水河谷 GM 通用汽车 417.47亿市值 474.37亿市值 415.69亿市值 9.74 49.34 133.29 -1.03(-2.04%) -2.45(-1.80%) -0.06(-0.63%) a 377.65亿市 ...

Core Viewpoint - The electrophysiology device market in China is experiencing rapid growth due to an aging population, increasing prevalence of arrhythmias, improved early screening rates, and advancements in electrophysiological procedures, with the market expected to reach over 40 billion yuan by 2032 [1][10][21]. Industry Overview - Electrophysiology devices are used to monitor and study electrical activities in biological systems, widely applied in medical, research, and clinical diagnosis fields. Common products include ECG machines, EEG machines, EMG machines, and electrophysiological navigation systems [2][4]. Industry Environment - The number of patients with rapid arrhythmias in China is projected to reach 28.2 million by 2024, driving demand for treatment. Electrophysiological surgeries have become a primary treatment method due to their advantages such as minimal invasiveness and high safety [6][8]. Industry Status - The market size for electrophysiology devices in China has grown from 2.42 billion yuan in 2017 to 12.55 billion yuan in 2024. The surgical volume for electrophysiology has increased from 138,000 cases in 2017 to 456,000 cases in 2024, indicating significant growth potential [10][8]. Competitive Landscape - The market is dominated by foreign companies such as Johnson & Johnson, Abbott, and Medtronic, which hold a combined market share of over 64%. Domestic companies like Huatai Medical and MicroPort EP have a much smaller share, indicating a high concentration in the industry [12][14]. Key Enterprises - MicroPort EP focuses on innovative medical devices for electrophysiology and has achieved significant revenue growth, with a projected income of 413 million yuan in 2024, up 25.51% [17]. Huatai Medical, specializing in electrophysiology and interventional medical devices, expects a revenue of 440 million yuan in 2024, reflecting a 19.73% increase [19]. Development Trends 1. **Accelerated Domestic Substitution**: Domestic brands are gaining market share due to supportive policies and technological advancements, with MicroPort EP and Huatai Medical leading in key areas [21]. 2. **Technological Innovation**: The industry is moving towards smart and precise technologies, enhancing the performance of electrophysiology devices and expanding clinical applications [22]. 3. **Growing Market Demand**: The demand for electrophysiology devices is surging, particularly in grassroots healthcare and international markets, with significant growth in overseas revenues for domestic companies [23].

Core Viewpoint - After a significant decline in stock price following a failed acquisition, Legend Biotech's stock showed signs of recovery due to strong sales data for its CAR-T product, CARVYKTI, but faced renewed pressure from competitive products and changing valuation logic [1][3][4]. Group 1: Stock Performance and Sales Data - Legend Biotech's stock price fell from a high of $58.90 in August last year to a low of $29.40 in April this year, marking a significant decline [1]. - On April 15, Johnson & Johnson reported that CARVYKTI achieved global sales of $369 million in Q1 2025, a year-over-year increase of 135%, exceeding market expectations of $324 million [1]. - Following the positive sales report, Legend Biotech's stock rose by 5.08% on the same day, contributing to a 3.01% increase in stock price for April [1]. Group 2: Competitive Landscape - The competitive landscape has shifted with Gilead's Kite company entering the market with Anito-cel, which has shown promising clinical data, including a 97% overall response rate in its trials [4][5]. - Anito-cel's data suggests it may offer comparable efficacy to CARVYKTI while potentially having a better safety profile, raising concerns about CARVYKTI's market share and pricing power [4][7]. - On May 14, following the release of Anito-cel's data, Legend Biotech's stock dropped by 10.55%, marking its largest single-day decline of the year [7]. Group 3: Financial Outlook and Production Capacity - Legend Biotech reported a net loss of $177 million for 2024, a significant reduction from a loss of $518.3 million the previous year, with CARVYKTI projected to generate $963 million in sales, a 92.7% increase [8][9]. - The company is expanding its production capacity, with plans to reach an annual capacity of 10,000 doses by the end of 2025 and 20,000 doses by the end of 2027 [9]. - Despite the positive sales outlook, the emergence of competitive products like Anito-cel poses challenges to Legend Biotech's growth strategy, raising questions about its reliance on CARVYKTI as a sole revenue driver [9][11]. Group 4: Product Pipeline and R&D - Legend Biotech has developed a diverse product pipeline, including multiple CAR-T therapies and other innovative treatments, but currently lacks a second product that can generate cash flow [11]. - The company has 11 products in development, indicating a potential delay in bringing additional revenue-generating products to market [11]. - The reliance on a single product for growth may place Legend Biotech at a disadvantage in the long-term market dynamics [11].

金十图示：2025年05月16日（周五）美股热门股票行情一览（美股收盘） VISA FEB 6738.43亿市值 7181.47亿市值 295.73亿市值 757.75 365.19 583.20 +25.96(+3.55%) +2.90(+0.80%) +1.00(+0.17%) 甲骨文 祭飞 埃克森美孚 5070.81亿市值 4662.60亿市值 4501.36亿市值 1191.53 108.19 160.52 +13.55(+1.15%) -0.39(-0.36%) +1.12(+0.70%) 强生 ss) 家得宝 P&G 宝浩 3828.17亿市值 3784.28亿市值 3640.39亿市值 163.28 151.30 380.74 +0.87(+0.54%) +1.69(+1.13%) +2.11(+0.56%) 阿斯麦 美国银行 可口可乐 (acobelia ASML 3366.00亿市值 3099.72亿市值 2940.27亿市值 747.62 72.02 44.69 +0.31(+0.70%) -10.74(-1.42%) +0.41(+0.57%) 赛富时 T-Mobile US Inc 联 ...